PS01 (P075) A retrospective review of isotretinoin treatment-related psychosexual health side-effects in a tertiary dermatology clinic

Presented after the UK regulator introduced new monitoring requirements for isotretinoin's psychiatric and sexual side effects, this retrospective review examined 167 consecutive patients who completed isotretinoin treatment at a tertiary dermatology clinic. The primary aim was mental-health outcomes (depressive symptoms, quality of life); the secondary endpoint was the effect of isotretinoin on sexual function. It represents real-world clinic data on psychosexual side effects collected under the new regulatory monitoring regime.